Results
21,632 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 27 | Soule Randy10% Owner |  SAFXXCF Global, Inc.Open-market sale | SELL | $32K 200.0K sh | Jan 14, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 27 | Soule Randy10% Owner | SAFXXCF Global, Inc. Open-market sale | SELL | $32K 200.0K sh | Jan 14, 2026 |
| 26 | DeHoff KateSee Remarks |  JOBYJoby Aviation, Inc.Open-market sale · 10b5-1 plan | SELL | $416K 28.3K sh | Jan 14, 2026 traded Jan 14, 2026 |
| 26 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $26K 296 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 26 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 296 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 25 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $107K 1,216 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 25 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 1,446 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 25 |  Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner |  ROKUROKU, INCOpen-market sale · 10b5-1 plan | SELL | $838K 7,799 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 25 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 1,446 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 25 | Ravid ChagayDirector, Chief Executive Officer |  SDOTSadot Group Inc.Open-market sale | SELL | $4,442 1,305 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 24 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $268K 3,191 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 24 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $518K 5,948 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 24 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $308K 3,573 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 23 | Fitzgerald Kevin JosephCSO & EVP, Head of Research |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 23 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 23 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 23 | DeHoff KateSee Remarks | JOBYJoby Aviation, Inc. Open-market sale · 10b5-1 plan | SELL | $105K 7,092 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $4,740 55 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $33K 381 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $11K 128 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $11K 127 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $4,654 54 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 482 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 164 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 776 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 869 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 775 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $167K 2,105 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $84K 986 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $122K 1,328 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | Saba Capital Management, L.P.10% Owner |  GFNEW GERMANY FUND INCOpen-market sale | SELL | $24K 2,000 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 868 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $53K 637 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $5,242 14 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 40 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $5,667 15 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $14K 39 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $18K 50 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $7,047 19 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Tuffin PaulaGeneral Counsel and CCO |  BETRBetter Home & Finance Holding CoOpen-market sale · 10b5-1 plan | SELL | $297K 7,698 sh | Jan 14, 2026 traded Jan 12, 2026 |